Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human fucosyltransferase VI [ FTVI ] + GDP-fucose |
---|---|
Date Designated: | 01/27/2015 |
Orphan Designation: | To increase the activity of regulatory T-cells (Tregs) used in the prevention of graft versus host disease in patients undergoing hematopoietic stem cell transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TargaZyme, Inc. 2100 Palomar Airport Road Suite 214-219 Carlsbad, California 92011 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-